# Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations

> **NCT02149823** · PHASE1 · TERMINATED · sponsor: **Maria de las Mercedes Perez Rodriguez** · enrollment: 92 (actual)

## Conditions studied

- Borderline Personality Disorder
- BPD
- Schizotypal Personality Disorder
- SPD
- Autism Spectrum Disorder
- Schizophrenia
- Schizoaffective Disorder
- Bipolar Disorder

## Interventions

- **DRUG:** Syntocinon 24 Intranasal Units (IU)
- **DRUG:** Syntocinon 40 Intranasal Units (IU)
- **DRUG:** Intranasal Placebo

## Key facts

- **NCT ID:** NCT02149823
- **Lead sponsor:** Maria de las Mercedes Perez Rodriguez
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2020-07
- **Final completion:** 2022-06-14
- **Target enrollment:** 92 (ACTUAL)
- **Why stopped:** All study proceedings stopped prematurely due to Covid-19 restrictions for intranasal formulations
- **Last updated:** 2022-10-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02149823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02149823, "Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02149823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*